Fig. 3. Smoothed spline plot of percentage of days with asthma control by treatment group versus smoking history (in pack years; A) and FEV1 percent predicted.

Slides:

Advertisements

Similar presentations

Fig. 1. Relationship between the number of cigarettes smoked per day and asthma control.3 Reproduced with permission from the Primary Care Respiratory.

Advertisements

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

Recognition and First-Line Treatment of Anaphylaxis

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Fig. 2. Comparison of the Th1/Th2 ratio and the percentages of Th1 and Th2 cells between normal and allergic individuals. (A) The Th1/Th2 ratio observed.

Immune function in cigarette smokers who quit smoking for 31 days

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD

Alalia Berry, MD, William W. Busse, MD

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Effect of montelukast for treatment of asthma in cigarette smokers

Overcoming barriers to nonadherence in asthma treatment

A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma Stanley J. Szefler, MD, Kevin Murphy,

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma Eric D. Bateman, MD, Udo-Michael.

Badrul A. Chowdhury, MD, PhD

A history of pollen mapping and surveillance: The relations between natural history and clinical allergy Gregg Mitman, PhD Journal of Allergy and Clinical.

Stanley J. Szefler, MD, Richard J. Martin, MD

Mark T. S. Chan, MDa, Donald Y. M. Leung, MD, PhDb, Stanley J

Excessive gestational weight gain in first trimester is a risk factor for exacerbation of asthma during pregnancy: A prospective study of 1283 pregnancies

Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients William W. Busse, MD, Sally E. Wenzel, MD, Eli O. Meltzer,

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial William Busse, MDa,

The impact of allergic rhinitis on bronchial asthma

Nonadherence to Asthma Treatment: Getting Unstuck

Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations Raymond G.

Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction Silvia Carraro, MD, Massimo Corradi,

Michael Mellon, MD Journal of Allergy and Clinical Immunology

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

News & Notes Journal of Allergy and Clinical Immunology

Wine-induced asthma: A placebo-controlled assessment of its pathogenesis Hassan Vally, BSc (Hons), Amanda Carr, BAppSc, Jacque El-Saleh, RN, Philip Thompson,

Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS

Insect sting allergy and venom immunotherapy: A model and a mystery

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma William.

What is an “eosinophilic phenotype” of asthma?

Exercise-induced bronchoconstriction in children: Montelukast attenuates the immediate-phase and late-phase responses Raul E. Melo, MD, Dirceu Solé,

Clinical need for a nebulized corticosteroid

Autophagy: Nobel Prize 2016 and allergy and asthma research

A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma Gordon D. Raphael, MDa, Robert.

News & Notes Journal of Allergy and Clinical Immunology

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma Eugene R. Bleecker, MDa, Michael J. Welch, MDb,

A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein.

E. Rand Sutherland, MD, MPH Journal of Allergy and Clinical Immunology

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids Michael Noonan, MD, Phillip Korenblat, MD, Sofia Mosesova, PhD,

Exercise-induced asthma: Is it the right diagnosis in elite athletes?

The National Institutes of Allergy and Infectious Diseases networks on asthma in inner- city children: An approach to improved care William W. Busse,

Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective Helen Donohoe, MSc (Econ)

Fig. 2. Putative mechanisms of oral tolerance induction in the gut

Fig. 3. Typical protocol for oral and sublingual immunotherapy

Nitric oxide as a clinical guide for asthma management

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: A randomized controlled trial Andrea J. Apter,

Larry C. Borish, MDa, Harold S

Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma Stanley J. Szefler, MD, Lars-Goran Carlsson,

Daniel Menzies, MBChB, Arun Nair, MBBS, Karen T

The correlation between allergic rhinitis and sleep disturbance

Fig. 4. The expression of TRAF6 in the PBMCs of the AR children after a 3-month SIT treatment. (A) Representative Western blot analysis of TRAF6 in the.

Riccardo Polosa, MD, PhD, James D

Diagnostic testing and interpretation of tests for autoimmunity

News & Notes Journal of Allergy and Clinical Immunology

Lisa A. Beck, MD, Sarbjit Saini, MD

Negative affect, medication adherence, and asthma control in children

Airway inflammation in chronic obstructive pulmonary disease

Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease Jaclyn Smith, MD, PhD, Emily Owen, MPhil, John Earis, MD,

Natural history of cow’s milk allergy

Differences in airway remodeling between subjects with severe and moderate asthma Carmela Pepe, MD, Susan Foley, MD, Joanne Shannon, MD, Catherine Lemiere,

Presentation transcript:

Fig. 3. Smoothed spline plot of percentage of days with asthma control by treatment group versus smoking history (in pack years; A) and FEV1 percent predicted at baseline (B).27 Reprinted from the Journal of Allergy and Clinical Immunology, 131(3). Price D, Popov TA, Bjermer L, Lu S, Petrovic R, Vandormael K, Mehta A, Strus JD, Polos PG, Philip G. Effect of montelukast for treatment of asthma in cigarette smokers. 2013;131(3):763-71. with permission from Elsevier. Fig. 3. Smoothed spline plot of percentage of days with asthma control by treatment group versus smoking history (in pack years; A) and FEV1 percent predicted at baseline (B).27 Reprinted from the Journal of Allergy and Clinical Immunology, 131(3). Price D, Popov TA, Bjermer L, Lu S, Petrovic R, Vandormael K, Mehta A, Strus JD, Polos PG, Philip G. Effect of montelukast for . . . Allergy Asthma Immunol Res. 2014 Mar;6(2):114-120. http://dx.doi.org/10.4168/aair.2014.6.2.114